IRWD
IRONWOOD PHARMACEUTICALS INC
+0.28 (+6.59%)4.45USD806K成交股數734M市值4.8本益比(近四季)1.9股價營收比+32.6%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 113M+33% | 107M+159% | 47.7M-47% | 122M+33% | 85.2M-10% | 41.1M-45% | 90.5M-23% | 91.6M-19% | 94.4M | 74.9M | 118M | 114M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 22.4M | 21.9M | – | 22.5M | 23.4M | 27.4M | – | 29.8M | 30.4M | 25.8M | – | 33.0M |
| 銷售管理費用 | 11.3M | 12.0M | – | 21.9M | 16.8M | 24.3M | – | 36.1M | 37.0M | 37.6M | – | 36.0M |
| 營業利益 | 79.3M+75% | 72.6M-349% | – | 75.5M+194% | 45.3M+81% | −29.1M-364% | – | 25.6M-36% | 25.0M | 11.0M | – | 40.0M |
| 營業利益率 | 70.2% | 68.1% | – | 61.8% | 53.2% | -70.7% | – | 28.0% | 26.5% | 14.7% | – | 35.2% |
| 稅後淨利 | 51.3M+117% | 40.8M-209% | −2.3M-201% | 40.1M+999% | 23.6M-2844% | −37.4M+798% | 2.3M-308% | 3.6M-76% | −860K | −4.2M | −1.1M | 15.3M |
| 淨利率 | 45.4% | 38.3% | -4.8% | 32.8% | 27.7% | -90.9% | 2.5% | 4.0% | -0.9% | -5.6% | -0.9% | 13.5% |
| 稀釋 EPS | 0.31+121% | 0.24-204% | -0.01-200% | 0.23+1050% | 0.14-1500% | -0.23+667% | 0.01-200% | 0.02-78% | -0.01 | -0.03 | -0.01 | 0.09 |
| 稀釋股數 | 167M | 167M | – | 178M | 177M | 161M | – | 160M | 159M | 158M | – | 187M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 79.1M | 220M | 215M | 140M | 92.9M | 108M | 88.6M | 88.2M | 106M | 122M | 92.2M | 110M |
| 應收帳款 | 113M | 106M | 46.7M | 120M | 86.2M | 39.8M | 81.9M | 76.2M | 58.1M | 72.0M | 129M | 125M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 285M | 435M | 397M | 396M | 343M | 327M | 351M | 390M | 396M | 439M | 471M | 524M |
| 有息負債 | – | – | – | 200M | 199M | 199M | 199M | 199M | 199M | 398M | 398M | 397M |
| 總負債 | 447M | – | 659M | – | – | – | – | – | – | – | – | – |
| 股東權益 | −162M | −217M | −262M | −264M | −308M | −334M | −301M | −311M | −322M | −331M | −346M | −323M |
| 負債比 | 156.8% | – | 166.0% | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | −59.1M | −106M | −90.7M | −110M | −111M | −93.1M | −277M | −306M | −287M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 5.1M-74% | – | – | – | 20.0M-56% | – | – | – | 45.0M | – | – |
| 資本支出 | – | – | – | – | – | 31K | – | – | – | 68K | – | – |
| 自由現金流 | – | – | – | – | – | 19.9M-56% | – | – | – | 44.9M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | 48.4% | – | – | – | 60.0% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 296M
| Collaborative Arrangements | 296M | 100.0% | -15.7% |
|---|---|---|---|
| Collaborative Arrangement Other Agreements | 87K | 0.0% | -88.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 296M | -15.7% | 24.0M | 8.1% | 0.15 | 127M |
| FY2024 | 351M | -20.6% | 880K | 0.3% | 0.01 | 103M |
| FY2023 | 443M | +7.8% | −1.0B | -233.0% | -6.45 | 183M |
| FY2022 | 411M | -0.8% | 175M | 42.6% | 0.96 | 274M |
| FY2021 | 414M | +6.2% | 528M | 127.7% | 3.21 | 262M |
| FY2020 | 390M | -9.1% | 106M | 27.3% | 0.66 | 167M |
| FY2019 | 428M | +23.6% | 21.5M | 5.0% | 0.14 | 3.5M |
| FY2018 | 347M | – | −282M | -81.5% | -1.85 | −71.2M |